Kardium

Diagnostic Equipment · Burnaby, Canada · Founded 2007 · Privately Held (backing)

Developer of medical devices designed to help in the diagnosis and treatment of atrial fibrillation. Kardium is based in Burnaby, Canada and was founded in 2007. It has raised $575 million across 3 recorded rounds; the latest was a $104 million later-stage round in May 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$575.2M
Last round
Later Stage VC
May 2024
Cap table — not yet on record

Kardium's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Kardium
  • ·8 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Frequently asked about Kardium

Where does Kardium's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kardium's 3 recorded funding rounds.